MedTrace Logo

Nutrilite Memory Builder on the Improvement of Cognitive Function

NCT05591885 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-04-28

No results posted yet for this study

Summary

Its a randomized controlled trial, to evaluate the effect of NUTRILITE Memory Builder on the improvement of cognitive function in middle-aged and elderly people.

Conditions

  • Cognitive Function

Interventions

DIETARY_SUPPLEMENT

Study product group (Nutrilite Memory Builder)

During study intervention, subjects are required to take the randomly assigned study product following the instructions.Take one tablet twice daily with meals.

DIETARY_SUPPLEMENT

Placebo group

During study intervention, subjects are required to take the randomly assigned placebo following the instructions.Take one tablet twice daily with meals.

Sponsors & Collaborators

  • Amway (China) R&D Center

    lead INDUSTRY

Principal Investigators

  • Wenan Wang, MD · Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-24
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05591885 on ClinicalTrials.gov